Anti‐growth and pro‐apoptotic effects of dasatinib on human oral cancer cells through multi‐targeted mechanisms

Dasatinib is an inhibitor of Src that has anti‐tumour effects on many haematological and solid cancers. However, the anti‐tumour effects of dasatinib on human oral cancers remain unclear. In this study, we investigated the effects of dasatinib on different types of human oral cancer cells: the non‐t...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Nam‐Sook, Park, Yu‐Kyung, Yadav, Anil Kumar, Shin, Young‐Min, Bishop‐Bailey, David, Choi, Jong‐Soon, Park, Jong Wook, Jang, Byeong‐Churl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419177/
https://www.ncbi.nlm.nih.gov/pubmed/34318593
http://dx.doi.org/10.1111/jcmm.16782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419177/
https://www.ncbi.nlm.nih.gov/pubmed/34318593
http://dx.doi.org/10.1111/jcmm.16782

Ejemplares similares